Mei-Chun Rao

MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway

P. Zhan, Mei-Chun Rao, Dongfeng Chen, 2019, Biology Direct.

MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway

P. Zhan, Mei-Chun Rao, Dongfeng Chen, 2019, Biology Direct.